Select Publications

Journal articles

Conway A; Marshall AD; Crawford S; Hayllar J; Grebely J; Treloar C, 2023, 'Deimplementation in the provision of opioid agonist treatment to achieve equity of care for people engaged in treatment: a qualitative study', Implementation Science, 18, http://dx.doi.org/10.1186/s13012-023-01281-4

Treloar C; Beadman K; Beadman M; Smith KA; Christian J; Jackson AC; Tyson B; Anderson C; Smyth L; Walker M; Heslop J; Gahan G; Tawil V; Sheaves F; Maher L; Page J; Tilley D; Ryan A; Grant K; Donovan B; Stevens A; Slattery T; Pearce K; John-Leader F; Walden A; Lenton J; Crowley M; Cama E, 2023, 'Evaluating a complex health promotion program to reduce hepatitis C among Aboriginal and Torres Strait Islander peoples in New South Wales, Australia: the Deadly Liver Mob', Harm Reduction Journal, 20, http://dx.doi.org/10.1186/s12954-023-00885-9

Cama E; Beadman M; Beadman K; Hopwood M; Treloar C, 2023, 'Health workers’ perspectives of hepatitis B-related stigma among Aboriginal and Torres Strait Islander people in New South Wales, Australia', Harm Reduction Journal, 20, http://dx.doi.org/10.1186/s12954-023-00844-4

Cama E; Beadman K; Beadman M; Smith KA; Christian J; Jackson AC; Tyson B; Anderson C; Smyth L; Heslop J; Gahan G; Tawil V; Sheaves F; Maher L; Page J; Tilley D; Ryan A; Grant K; Donovan B; Stevens A; Slattery T; Pearce K; John-Leader F; Walden A; Lenton J; Crowley M; Treloar C, 2023, 'Increasing access to screening for blood-borne viruses and sexually transmissible infections for Aboriginal and Torres Strait Islander Australians: evaluation of the Deadly Liver Mob program’s ‘cascade of care’ across nine sites in New South Wales, Australia', Harm Reduction Journal, 20, http://dx.doi.org/10.1186/s12954-023-00850-6

Cama E; Beadman K; Beadman M; Walker M; Treloar C, 2023, 'Insights from the scale-up and implementation of the Deadly Liver Mob program across nine sites in New South Wales, Australia, according to the RE-AIM framework', Harm Reduction Journal, 20, http://dx.doi.org/10.1186/s12954-023-00889-5

Broom A; Peterie M; Ridge D; Lafferty L; Kenny K; Broom J; Kelly-Hanku A; Treloar C; Applegate T, 2023, 'Sex, drugs and superbugs: The rise of drug resistant STIs', SSM - Qualitative Research in Health, 4, http://dx.doi.org/10.1016/j.ssmqr.2023.100310

Hobday S; Valerio H; Combo T; Monaghan R; Scott C; Silk D; Murray C; Read P; Henderson C; Degenhardt L; Treloar C; Dore GJ; Grebely J; Martinello M, 2023, 'Evaluating the prevalence of current hepatitis C infection and treatment among Aboriginal and Torres Strait Islander peoples who inject drugs in Australia: The ETHOS engage study', Drug and Alcohol Review, 42, pp. 1617 - 1632, http://dx.doi.org/10.1111/dar.13723

Fomiatti R; Pienaar K; Savic M; Keane H; Treloar C, 2023, 'Improving understandings of trauma and alcohol and other drug-related problems: A social research agenda', International Journal of Drug Policy, 121, http://dx.doi.org/10.1016/j.drugpo.2023.104198

Sivak L; Reilly R; Lockton J; Treloar C; Roe Y; McKetin R; Butt J; Ezard N; Winkenweder H; Ward J, 2023, 'Psychosocial stress and methamphetamine use: A mixed-methods study of intersectional stigma and Aboriginal and Torres Strait Islander methamphetamine use', International Journal of Drug Policy, 121, http://dx.doi.org/10.1016/j.drugpo.2023.104189

Nourse G; Farrugia A; Fraser S; Moore D; Treloar C, 2023, 'Optimism and eternal vigilance: Gathering disease, responsible subjects and the hope of elimination in the new hepatitis C treatment era', International Journal of Drug Policy, 119, http://dx.doi.org/10.1016/j.drugpo.2023.104142

Conway A; Krawczyk N; McGaffey F; Doyle S; Baaklini V; Marshall AD; Treloar C; Davis CS; Colledge-Frisby S; Grebely J; Cerdá M, 2023, 'Typology of laws restricting access to methadone treatment in the United States: A latent class analysis', International Journal of Drug Policy, 119, http://dx.doi.org/10.1016/j.drugpo.2023.104141

Broady TR; Brener L; Horwitz R; Cama E; Treloar C, 2023, 'Reducing stigma towards people living with HIV and people who inject drugs using social norms theory: An online study with Australian health care workers', Drug and Alcohol Dependence, 249, http://dx.doi.org/10.1016/j.drugalcdep.2023.109953

Schroeder SE; Treloar C; Bourne A; Stoové M; Doyle J; Hellard M; Pedrana A, 2023, 'Pre-Empting Stigma and Complicating Trauma: Narratives of Gay and Bisexual Men who Inject Drugs in Australia', Qualitative Health Research, 33, pp. 688 - 700, http://dx.doi.org/10.1177/10497323231173788

Wand H; Reilly R; McKetin R; Quinn B; Roe Y; Conigrave K; Ezard N; Butt J; Treloar C; Sivak L; Shackleford I; Dunlop A; Ward J, 2023, 'Investigating associations between methamphetamine use, mental health and risky sexual behaviours amongst Aboriginal and Torres Strait Islander peoples', Mental Health and Prevention, 30, http://dx.doi.org/10.1016/j.mhp.2023.200267

Lafferty L; Sheehan Y; Cochrane A; Grebely J; Lloyd AR; Treloar C, 2023, 'Reducing barriers to the hepatitis C care cascade in prison via point-of-care RNA testing: a qualitative exploration of men in prison using an integrated framework', Addiction, 118, pp. 1153 - 1160, http://dx.doi.org/10.1111/add.16137

Clay S; Treloar C; Degenhardt L; Grebely J; Christmass M; Gough C; Hayllar J; McDonough M; Henderson C; Crawford S; Farrell M; Marshall A, 2023, '‘I just thought that was the best thing for me to do at this point’: Exploring patient experiences with depot buprenorphine and their motivations to discontinue', International Journal of Drug Policy, 115, http://dx.doi.org/10.1016/j.drugpo.2023.104002

Conway A; Treloar C; Crawford S; Degenhardt L; Dore GJ; Farrell M; Hayllar J; Grebely J; Marshall AD, 2023, '“You'll come in and dose even in a global pandemic”: A qualitative study of adaptive opioid agonist treatment provision during the COVID-19 pandemic', International Journal of Drug Policy, 114, http://dx.doi.org/10.1016/j.drugpo.2023.103998

Marshall AD; Martinello M; Zolopa C; Treloar C; Larney S, 2023, 'Universal hepatitis C virus screening and treatment as part of prenatal care', The Lancet Gastroenterology and Hepatology, 8, pp. 295 - 297, http://dx.doi.org/10.1016/S2468-1253(22)00421-6

Broady TR; Brener L; Caruana T; Cama E; Treloar C, 2023, 'Factors associated with sharing equipment among people who inject drugs: The role of community attachment in harm reduction and health promotion', Drug and Alcohol Review, 42, pp. 561 - 568, http://dx.doi.org/10.1111/dar.13606

Lancaster K; Gendera S; Treloar C; Rhodes T; Shahbazi J; Byrne M; Degenhardt L; Farrell M, 2023, 'The Social, Material, and Temporal Effects of Monthly Extended-Release Buprenorphine Depot Treatment for Opioid Dependence: An Australian Qualitative Study', Contemporary Drug Problems, 50, pp. 105 - 120, http://dx.doi.org/10.1177/00914509221140959

Treloar C; Rance J; Bryant J; Lafferty L, 2023, '‘There's too much power in this number. It's freaking the whole response out’: The views of key informants on evidence and targets to achieve hepatitis C elimination goals in Australia', Journal of Viral Hepatitis, http://dx.doi.org/10.1111/jvh.13896

Graham S; Martin K; Gardner K; Beadman M; Doyle MF; Bolt R; Murphy D; Newman CE; Bell S; Treloar C; Browne AJ; Aggleton P; Beetson K; Brooks M; Botfield JR; Davis B; Wilms J; Leece B; Stanbury L; Bryant J, 2023, 'Aboriginal young people’s perspectives and experiences of accessing sexual health services and sex education in Australia: A qualitative study', Global Public Health, 18, http://dx.doi.org/10.1080/17441692.2023.2196561

Treloar C; Idle J; valentine K, 2023, 'Child Sexual Abuse, Alcohol and Other Drug use and the Criminal Justice System: The Meanings of Trauma in Survivor Narratives for a National Royal Commission', Qualitative Health Research, 33, pp. 117 - 126, http://dx.doi.org/10.1177/10497323221144923

Moore D; Fraser S; Farrugia A; Fomiatti R; Edwards M; Birbilis E; Treloar C, 2023, 'Countering ‘the moral science of biopolitics’: Understanding hepatitis C treatment ‘non-compliance’ in the antiviral era', Sociology of Health and Illness, http://dx.doi.org/10.1111/1467-9566.13712

Peterie M; Broom A; Kenny K; Broom J; Regan D; Lafferty L; Kelly-Hanku A; Treloar C, 2023, 'Economies of resistance', Critical Public Health, http://dx.doi.org/10.1080/09581596.2023.2271140

Hajarizadeh B; Carson JM; Byrne M; Grebely J; Cunningham E; Amin J; Vickerman P; Martin NK; Treloar C; Martinello M; Lloyd AR; Dore GJ, 2023, 'Incidence of hepatitis C virus infection in the prison setting: The SToP-C study', Journal of Viral Hepatitis, http://dx.doi.org/10.1111/jvh.13895

Martin K; Bryant J; Beetson K; Wilms J; Briggs T; Treloar C; Newman C, 2023, 'Normalising sex and resisting shame: young Aboriginal women’s views on sex and relationships in an urban setting in Australia', Journal of Youth Studies, http://dx.doi.org/10.1080/13676261.2023.2225422

Conway A; Treloar C; Crawford S; Grebely J; Marshall AD, 2023, 'People engaged in opioid agonist treatment as a counterpublic during the COVID-19 pandemic in Australia: A qualitative study', Drug and Alcohol Review, 42, pp. 203 - 212, http://dx.doi.org/10.1111/dar.13531

Walker S; Dietze P; Higgs P; Ward B; Treloar C; Stoové M; Rathnayake K; Doyle J; Hellard M; Maher L, 2023, 'Socioeconomic consequences of the COVID-19 pandemic for people who use drugs', Australian Journal of Social Issues, http://dx.doi.org/10.1002/ajs4.289

Brener L; Broady T; Cama E; Treloar C, 2023, 'The impact of sources of stigma on health care avoidance among gay and bisexual men in Australia', AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, 35, pp. 663 - 671, http://dx.doi.org/10.1080/09540121.2022.2057410

Lafferty L; Schroeder S; Marshall AD; Drysdale K; Higgs P; Stoové M; Baldry E; Dietze P; Treloar C, 2023, 'Trust and service engagement among people who inject drugs after release from prison', International Journal of Drug Policy, 111, http://dx.doi.org/10.1016/j.drugpo.2022.103925

Broom A; Peterie M; Kenny K; Broom J; Kelly-Hanku A; Lafferty L; Treloar C; Applegate T, 2023, 'Vulnerability and antimicrobial resistance', Critical Public Health, 33, pp. 308 - 317, http://dx.doi.org/10.1080/09581596.2022.2123733

Bryant J; Bolt R; Martin K; Beadman M; Doyle M; Treloar C; Bell S; Murphy D; Newman C; Browne A; Aggleton P; Beetson K; Brooks M; Wilms J; Leece B; Stanbury L; Botfield J; Davis B; Graham S, 2023, 'Yarning as a method for building sexual wellbeing among urban Aboriginal young people in Australia', Culture, Health and Sexuality, http://dx.doi.org/10.1080/13691058.2023.2258948

Marshall AD; Schroeder SE; Lafferty L; Drysdale K; Baldry E; Stoové M; Dietze P; Higgs P; Treloar C, 2023, 'Perceived access to opioid agonist treatment in prison among people with a history of injection drug use: A qualitative study.', J Subst Use Addict Treat, 150, pp. 209066, http://dx.doi.org/10.1016/j.josat.2023.209066

Treloar C; Cama E; Lancaster K; Brener L; Broady TR; Cogle A; O’Donnell D, 2022, 'A universal precautions approach to reducing stigma in health care: getting beyond HIV-specific stigma', Harm Reduction Journal, 19, http://dx.doi.org/10.1186/s12954-022-00658-w

Valerio H; Conway A; Alavi M; Treloar C; Silk D; Murray C; Henderson C; Amin J; Read P; Degenhardt L; Christmass M; Montebello M; Dore GJ; Grebely J, 2022, 'Awareness of hepatitis C virus infection status among people who inject drugs in a setting of universal direct-acting antiviral therapy: The ETHOS Engage study', International Journal of Drug Policy, 110, http://dx.doi.org/10.1016/j.drugpo.2022.103876

Silano JA; Treloar C; Leadbeatter K; Davidson S; Doidge J, 2022, 'Peer-facilitated treatment access for hepatitis C: the Live Hep C Free project', Harm Reduction Journal, 19, http://dx.doi.org/10.1186/s12954-022-00619-3

Silano JA; Treloar C; Wright T; Brown T; McGrath C; Snoyman P, 2022, 'Commentary on the harm reduction reference group of justice health and forensic mental health network and corrective services NSW, Australia', International Journal of Prisoner Health, 18, pp. 394 - 406, http://dx.doi.org/10.1108/IJPH-06-2021-0050

Wallace J; Richmond J; Howell J; Hajarizadeh B; Power J; Treloar C; Revill PA; Cowie B; Wang S; Stoové M; Pedrana A; Hellard M, 2022, 'Exploring the Public Health and Social Implications of Future Curative Hepatitis B Interventions', Viruses, 14, http://dx.doi.org/10.3390/v14112542

Carson JM; Dore GJ; Lloyd AR; Grebely J; Byrne M; Cunningham E; Amin J; Vickerman P; Martin NK; Treloar C; Martinello M; Matthews GV; Hajarizadeh B, 2022, 'Hepatitis C Virus Reinfection Following Direct-Acting Antiviral Treatment in the Prison Setting: The SToP-C Study', Clinical Infectious Diseases, 75, pp. 1809 - 1819, http://dx.doi.org/10.1093/cid/ciac246

Zhang Y; Guy R; Camara H; Applegate TL; Wiseman V; Treloar C; Lafferty L, 2022, 'Barriers and facilitators to HIV and syphilis rapid diagnostic testing in antenatal care settings in low-income and middle-income countries: A systematic review', BMJ Global Health, 7, http://dx.doi.org/10.1136/bmjgh-2022-009408

Jin D; Brener L; Treloar C, 2022, 'Hepatitis B-related stigma among Chinese immigrants living with hepatitis B virus in Australia: A qualitative study', Health and Social Care in the Community, 30, pp. e5602 - e5611, http://dx.doi.org/10.1111/hsc.13986

Marshall AD; Martinello M; Treloar C; Matthews GV, 2022, 'Perceptions of hepatitis C treatment and reinfection risk among HIV-positive men who have sex with men and engage in high risk behaviours for hepatitis C transmission: The CEASE qualitative study', International Journal of Drug Policy, 109, http://dx.doi.org/10.1016/j.drugpo.2022.103828

Jin D; Brener L; Treloar C, 2022, 'Trust in healthcare providers among Chinese immigrants living with hepatitis B virus in Australia: A qualitative study', Journal of Viral Hepatitis, 29, pp. 968 - 975, http://dx.doi.org/10.1111/jvh.13736

Drysdale K; Rance J; Cama E; Treloar C; Mao L, 2022, 'What is known about the care and support provided for an ageing population with lived experience of chronic viral hepatitis as they near end-of-life: A scoping review', Health and Social Care in the Community, 30, pp. e3775 - e3788, http://dx.doi.org/10.1111/hsc.14066

Treloar C; Lancaster K; Gendera S; Rhodes T; Shahbazi J; Byrne M; Degenhardt L; Farrell M, 2022, 'Can a new formulation of opiate agonist treatment alter stigma?: Place, time and things in the experience of extended-release buprenorphine depot', International Journal of Drug Policy, 107, http://dx.doi.org/10.1016/j.drugpo.2022.103788

Fraser S; Moore D; Farrugia A; Fomiatti R; Edwards M; Birbilis E; Treloar C, 2022, 'Exhausted practical sovereignty and lateral agency: Non-uptake of treatment for hepatitis C in the antiviral era', International Journal of Drug Policy, 107, http://dx.doi.org/10.1016/j.drugpo.2022.103771

Lafferty L; Rance J; Byrne M; Milat A; Dore GJ; Grebely J; Lloyd AR; Treloar C, 2022, '“You need a designated officer” – Recommendations from correctional and justice health personnel for scaling up hepatitis C treatment-as-prevention in the prison setting', International Journal of Drug Policy, 106, http://dx.doi.org/10.1016/j.drugpo.2022.103746

Wheeler A; Valerio H; Cunningham EB; Martinello M; Barocas JA; Colledge-Frisby S; Treloar C; Amin J; Henderson C; Read P; Matthews GV; Dunlop AJ; Gorton C; Hayllar J; Alavi M; Murray C; Marks P; Silk D; Degenhardt L; Dore GJ; Grebely J, 2022, 'Prevalence and factors associated with hospitalisation for bacterial skin infections among people who inject drugs: The ETHOS Engage Study', Drug and Alcohol Dependence, 237, http://dx.doi.org/10.1016/j.drugalcdep.2022.109543

Conway A; Valerio H; Alavi M; Silk D; Treloar C; Hajarizadeh B; Marshall AD; Martinello M; Milat A; Dunlop A; Murray C; Prain B; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Hayllar J; Reid D; Gorton C; Lam T; Christmass M; Wade A; Montebello M; Dore GJ; Grebely J, 2022, 'A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage Study', Viruses, 14, http://dx.doi.org/10.3390/v14071555


Back to profile page